Premium
Positive cooperative regulation of double binding sites for human acetylcholinesterase
Author(s) -
Liu Hao,
Ye Wei,
Chen HaiFeng
Publication year - 2017
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.12891
Subject(s) - neurotransmission , acetylcholinesterase , acetylcholine , neurotransmitter , neuroscience , biology , synaptic cleft , biochemistry , chemistry , enzyme , pharmacology , central nervous system , receptor
Acetylcholinesterase is a potent enzyme that regulates neurotransmission by rapidly hydrolyzing the neurotransmitter acetylcholine in synapses of the nervous system. As drug target of anti‐AD, it has catalytic and peripheral anionic sites. However, the regulation relation between these two sites is unclear. Therefore, we constructed dynamics fluctuation network based on all‐atom molecular dynamics simulations to reveal the regulation mechanism. The results suggest that the correlation network in double‐site system ( hAChE / TZ 5) is distinctly different from that in the free state and single‐site systems ( hAChE /huprine and hAChE /1 YL ). The community network analysis indicates that the information freely transfers from the peripheral anionic site to the catalytic active site in hAChE / TZ 5. Furthermore, the binding free energy between the inhibitor and hAChE for hAChE / TZ 5 is significantly lower than of either hAChE /huprine or hAChE /1 YL . Thus, a hypothesis of ‘positive cooperative regulation’ is proposed for the regulation of double binding sites and further confirmed by the weakening and mutation community analyses. Finally, one possible cooperative regulation pathway of W86‐ TZ 5‐W286 was identified based on the shortest path algorithm and was confirmed by the network perturbation analysis. Interestingly, the regulation pathway for single‐site systems is significantly different from that of dual‐site system. The process targeting on the shortest pathway can better regulate the hydrolyzing the neurotransmitter acetylcholine and significantly inhibit the aggregation of Aβ amyloid.